Effect of Isoniazid Prophylaxis Therapy on the Prevention of Tuberculosis Incidence and Associated Factors Among HIV Infected Individuals in Northwest Ethiopia: Retrospective Cohort Study

References

• Cain PK, McCarthy DK, Heilig MC, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med. 2010;362(8):707–716. doi:10.1056/NEJMoa0907488
   Web of Science ®Google Scholar
• Raviglione MC. Tuberculosis - the Essentials. 4th ed. Geneva: World Health Organization; 2010.
   Google Scholar
• World Health Organization. Global tuberculosis report, end TB 2019.
   Google Scholar
• Addis Ababa Report on National TB/HIV sentinel surveillance. 2015.
   Google Scholar
• Wondimeneh Y, Muluye D, Belyhun Y. Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes. 2012;5:331. doi:10.1186/1756-0500-5-331
   Google Scholar
• Nigatu DF, Kiros DM, Mamo MS, et al. Ethiopian consolidated national guidelines for HIV prevention, care and treatment- final version December 17, 2014.
   Google Scholar
• Africa DohRoS. National tuberculosis management guidelines. 2014.
   Google Scholar
• Keder DF, Getachew MM, Mamo SS, et al. National consolidated guidelines for comprehensive HIV prevention, care and treatment. 2018.
   Google Scholar
• Volmink J, Woldehanna S. Treatment of latent tuberculosis infection in HIV infected persons (sytematic review). Cochrane Lib. 2004;3.
   Google Scholar
• Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD, Pape JW. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. The Lancet. 2000;356:1470–1474. doi:10.1016/S0140-6736(00)02870-1
   PubMed Web of Science ®Google Scholar
• Semu M, Fenta TG, Medhin G, Assefa D. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017;17:1–8. doi:10.1186/s12879-016-2109-7
   Web of Science ®Google Scholar
• Gordin MFM, Miller JP, Brown C, et al. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med. 1997;337(5):315–320. doi:10.1056/NEJM199707313370505
   PubMed Web of Science ®Google Scholar
• Word Vision. Technical guideline for tuberculosis (TB) and TB-HIV program implementation. World Vision. 2017;13:87–95.
   Google Scholar
• Ahn JV, Bailey H, Malyuta R, Volokha A, Thorne C. Factors associated with non-disclosure of HIV status in a cohort of childbearing HIV-positive women in Ukraine. AIDS Behav. 2016;20(1):174–183. doi:10.1007/s10461-015-1089-8
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report. 2018.
   Google Scholar
• World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva, Switzerland: World Health Organization; 2011.
   Google Scholar
• Ethiopa FMoHo. National comprehensive HIV care and treatment training for health care providers, practical manua. ART guideline. 2014.
   Google Scholar
• Sileshi B, Deyessa N, Girma B, Melese M, Suarez P. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2013;13(297):1471–2334. doi:10.1186/1471-2334-13-297
   Web of Science ®Google Scholar
• Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One. 2013;8(5):e64488. doi:10.1371/journal.pone.0064488
   Web of Science ®Google Scholar
• Assebe LF, Reda HL, Wubeneh AD, et al. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health. 2015;15(1):346. doi:10.1186/s12889-015-1719-0
   Web of Science ®Google Scholar
• Fekadu S, Teshome W, Alemu G. Prevalence and determinants of Tuberculosis among HIV infected patients in south Ethiopia. J Infect Dev Ctries. 2015;9(8):898–904. doi:10.3855/jidc.5667
   Web of Science ®Google Scholar
• Abossie A, Yohanes T. Assessment of isoniazid preventive therapy in the reduction of tuberculosis among aRT patients in arba Minch hospital, ethiopia. Ther Clin Risk Manag. 2017;13:361. doi:10.2147/TCRM.S127765
   PubMed Web of Science ®Google Scholar
• Choun TK, Thai S, Pe R, et al. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg. 2013;107(4):235–242. doi:10.1093/trstmh/trt001
   Web of Science ®Google Scholar
• Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. Afr Health Sci. 2016;16(2):588–595. doi:10.4314/ahs.v16i2.29
   Web of Science ®Google Scholar
• Goluba JE, Pronykc P, Mohapie L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23(5):631–636. doi:10.1097/QAD.0b013e328327964f
   Web of Science ®Google Scholar
• Ethiopia CSAo. Ethiopian population projection census 2015. 2015.
   Google Scholar
• Simbayi LC, Kalichman SC, Strebel A, Cloete A, Henda N, Mqeketo A. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect. 2007;83(1):29–34. doi:10.1136/sti.2006.019893
   PubMed Web of Science ®Google Scholar
• Yirdaw KD, Jerene D, Gashu Z, et al. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoS One. 2014;9(8):e104557. doi:10.1371/journal.pone.0104557
   PubMed Web of Science ®Google Scholar
• Molaeipoor L, Poorolajal J, Mohraz M. Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control study. Epidemiol Health. 2014;36. doi:10.4178/epih/e2014024
   Google Scholar
• Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in southwest ethiopia: a case control study. Ethiop J Health Sci. 2011;21(2):131–140. doi:10.4314/ejhs.v21i2.69053
   PubMedGoogle Scholar
• Geleto A, Abate D, Egata G. Intensified tuberculosis case finding, implementation of isoniazid preventive therapy and associated factors among people living with human immunodeficiency virus at public health facilities of Harari Region, Eastern Ethiopia: a cross-sectional study. Int J Health Sci. 2017;11(1):1.
   Google Scholar
• Cui Z, Lin M, Nie S, Lan R. Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: a pair-matched case-control study in Guangxi, China. PLoS One. 2017;12(3):e0173976. doi:10.1371/journal.pone.0173976
   Web of Science ®Google Scholar